Gas-Chromatographic Analysis for Phencyclidine in Plasma, with Use of a Nitrogen Detector
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We describea reliable gas-chromatographic analysisfor unchanged phencyclidine in human plasma, with use of a nitrogendetector. The assay issufficiently sensitive to permit measurement of as little as 5 tg of the drug per liter, in 2 mL of plasma. Phencyclidine is extracted from plasma atpH 10.5 into hexane/iso-amylalcoholcontaining meperidine as the internal standard,back-extractedinto dilute HCI, and re-extracted into hexane/iso-amyl alcohol after alkalinization of the HCI. The coefficients of variation forthe analysisat respective concentrations of 100 and 200 .rg/L are: within-run, 4.0% and 3.4%; between-run, 2.8% and 5.2%. This procedure, used in our laboratory for more than one year, has been applied to plasma from numerous individuals with nonfatal phencyclidine intoxication. Some representative examples are given.
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Abuse of phencyclidine [1-( 1-phenylcyclohexyl)piperidine, "PCP," "angel dust"] ( Figure 1A (11, 12) , we have utilized a gas-chromatographic analysisforunchanged phencyclidine,with use of a nitrogen detector. This analysis is suitable for routine use in the clinical laboratory and is sufficiently sensitive to permit measurement of the drug in plasma. Here we report this procedure in detail as it has been used in our laboratory for more than one year.
Materials and Methods
Apparatus
We used a Model 3920B gas-liquid chromatograph equipped with a nitrogen-phosphorus detector (Perkin-Elmer Corp., Norwalk, CT 06582) and a coiled glass column (1.8 m X 2 mm i. To prepare the internal standard, dissolve 10 mg of meperidine hydrochloride in 10 mL of methanol.
Dilute standards. For the internal standard, add 5 sL (5 gig) of the 1.00 g/L stock meperidine hydrochloride standard to each 100 mL of hexane/iso-amyl alcohol (98/2 by vol) used for the initial extraction.
This provides 250 ng of internal standard per milliliter of plasma extracted. Store in an amber-colored glass bottle at room temperature. Prepare at leastonce a month.
For thephencyclidine standard (10 mg/L), evaporate 100 sL (100 sg) of the 1.00 g/L stock phencyclidine standard. Dissolve the residue in 10 mL of methanol.
Prepare freshly at the time of analysis.
For the phencyclidine/meperidine column-saturation so lution (500 mg/L), combine 0.5 mL of each of the 1.00 g/L stock standards of phencyclidine and meperidine hydrochloride. Store at -20 #{176}C. Prepare at least once per month.
For the phencyclidine/meperidine detector-calibration solution (20 mg/L), evaporate 100 L (100 g) of each of the 1.00 g/L stock standards of phencyclidine and meperidine hydrochloride.
Dissolve the combined residues in 5 mL of methanol.
Store at -20 #{176}C. Prepare freshly at least once a week.
Working standards in plasma. For the phencyclidine control in plasma (100 tg/L), evaporate 100 tL (1tg) of the dilutephencyclidinestandard and dissolve the residue in 10 mL of drug-free plasma. The control is stable for at least two weeks at -20 #{176}C.
Procedure
All glassware was soaked in 1 mol/L HC1 overnight, rinsed with water, and dried. The glassware was rinsed with hexane immediately before use. Blood samples were drawn into evacuated glass tubes containing potassium oxalate and sodium fluoride ("Vacutainer Tubes"; Becton-Dickinson, Rutherford, NJ 07070). The samples were centrifuged and the plasma stored at -20 #{176}C untilanalyzed.
Pipet 2 mL of plasma (samples, plasma standards, and plasma control) into 15-mL glass culture tubes equipped with Teflon-lined screw caps. Adjust the pH to about 10.5 with 0.5 mL of saturated Na2CO3. Add 10 mL of dilute internal standard in hexane/iso-amyl alcohol and extract vigorously for 15 mm. Centrifuge (3000 X g for 5 mm) and transfer the solvent (upper)layerto a second 15-mL screw-capped tube. Add 1 mL of 0.1 mol/L HCI, extractgently for 15 mm, and, aftercentrifugation, aspirateand discard the solvent (upper) phase. Wash the acid for 1 mm with 2 mL of hexane only (no internal standard or iso-amyl alcohol), centrifuge, and discard the solvent (upper) layer. With a calibrated spatula add about 500 mg of anhydrous Na2CO3 to the acid to adjust the pH to approximately 10.5. Mix well and extract for 5 mm with 2 mL of hexane/iso-amyl alcohol that does not contain the internal standard.
Centrifuge, transfer the solvent (upper) phase to a 15-mL glass centrifuge tube, and remove residual water by adding about 500 mg of anhydrous Na2SO4 with a calibrated spatula. Transfer the dehydrated liquid extract to a glass tube designed for concentration (e.g., "Concentratube"; Laboratory Research Co., Los Angeles, CA 90036). Evaporate the solvent at room temperature under a gentle current of nitrogen, then rinse the sides of the tube with a few drops of hexane/iso-amyl alcohol not containing the internal standard and re-evaporate the solvent, so as to concentrate the residue in the tip of the tube.
Dissolve the extract residue in 10 jzL of methanol and chromatograph 2 1cL of the solutionunder the following conditions: column temperature, 200 #{176}C (isothermal); injector temperature, 250 #{176}C; detector temperature, 300 #{176}C; bead temperature, approximately 350-400 #{176}C; carrier gas (nitrogen) flow rate, 23 mL/min; hydrogen flow rate, 1-2 mL/min; amplifier setting, Xl. Identify phencyclidine from its retention time (1.50) relative to that of the meperidine internal standard (Figure 2 ). Calculate the peak-height ratio (ratio of the peak height of phencyclidine to that of the meperidine internal standard)
for each sample and determine the plasma concentration by comparison with the peak-height ratios (relative peak heights) of the extracted plasma standards. Before analysis of the extract residues it is desirable to "prime" the column with several2-zL (1-sg)injections of the phencyclidine/meperidine column-saturation solution; then inject methanol until peak "ghosting" no longer occurs. With each run the detector-bead current should be adjusted so that injection of 2 zL (40 ng) of the phencyclidine/meperidine detector-calibration solution produces a phencyclidine peak height of at least 50 mm at the chromatographic attenuation selected.
Results
A standard curve was prepared by supplementing drug-free plasma with phencyclidine.
A plot of concentration (x) vs relative peak height (y) was linear (r = 0.99) for nine concentrations in the 5-500 sg/L range studied (least-squares regression equation: y = 0.0014x + 0.0193). Although less than 1 ng of phencyclidine could be detected by this procedure, plasma "background" limited the analytical sensitivity of the method to 5 g/L in 2 mL of plasma.
Analysis of multiple drug-free plasmas by the proposed procedure yielded no interfering peaks, although there were noninterfering peaks at retention times of 0.50 and 1.20 relative to the meperidine internal standard (Figure 2 , peaks a and c). The mean uncorrected analytical recovery was 52%, calculated by comparison of peak heights obtained from Forty common basic drugs (Table 1) were screened for interference in the proposed assay by comparing retention times of their nonextracted methanolic solutions with those of phencyclidine and the meperidine internal standard under the chromatographic conditions of the analysis. Acidic drugs were not studied since they would not be extracted under the alkaline (pH 10.5) conditions of the assay. Diphenhydramine (Benadryl, Parke-Davis) had the same retention time as phencyclidine; methylphenidate (Ritalin; CIBA) had the same retention time as the meperidine internal standard. These interferences persisted when drug-free plasma was supplemented to a concentration of 100 g/L with these two compounds and extracted.
Analysis of plasma from patients receiving diphenhydramine would thus show false-positive results in the absence of phencyclidine, or falsely high results in itspresence. Analysis of plasma from patients receiving methylphenidate would yield falsely low concentrations of phencyclidine because of the enhancement of the chromatographic response to the internalstandard.
We have used this method for more than one year for analysis of plasma samples from patients with nonfatal phencyclidine intoxication. Plasma drug concentrations from 15 of these patients are presented in Table  2 , and the chromatogram of one such analysis is shown in Figure 2 . cyclidine. However, the major metabolites, 4-phenyl-4-piperidinocyclohexanol and 1-( 1-phenylcyclohexyl)-4-hydroxypiperidine,are considered to be pharmacologically inactive and need not be measured (13) (14) (15) Tubes. In addition, all samples were centrifuged promptly after collection, and the plasma was quickly removed and frozen (-20 #{176}C).
Discussion
We selectedmeperidine as the internalstandard for the assay because of its structural, chemical, and chromatographic similarity to phencyclidine ( Figure IB) . Although meperidine is a prescribed narcotic (Demerol; Winthrop), it is not usually abused with phencyclidine.
If both meperidine and methyl phenidate, which extracts and chromatographs as meperidmne, are suspected to be present either from the clinical history, by preliminary analysis of the plasma without internal standard, or from routine thin-layer chromatographic analysis of urine for drugs of abuse, then another internal standard should be used, preferably one of the drugs listed in Table 1 ; except as previously noted, those drugs do not interfere in the analysis.
Diphenhydramine, a widely used antihistamine, is extracted and chromatographed identically to phencyclidine. Therefore, if diphenhydramine is suspected from the clinical history or from other toxicologic analyses, other chromatographic conditions should he used. During the more than one year we have been using the assay, however, we have not encountered phencyclidine simultaneously with meperidine, methylphenidate, or diphenhydramine at the time of the patient's admission to the hospital. We recommend the proposed procedure for routine use in the clinical laboratory.
